Jennison Associates’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,663,905
Closed -$12.2M 622
2025
Q2
$12.2M Buy
1,663,905
+136,638
+9% +$1.1M 0.01% 367
2025
Q1
$14.5M Buy
1,527,267
+12,511
+0.8% +$156K 0.01% 362
2024
Q4
$25M Buy
1,514,756
+238,288
+19% +$3.7M 0.02% 325
2024
Q3
$18.8M Buy
1,276,468
+57,041
+5% +$893K 0.01% 347
2024
Q2
$16.9M Buy
1,219,427
+167,800
+16% +$2.38M 0.01% 343
2024
Q1
$16.5M Buy
1,051,627
+460,071
+78% +$7.1M 0.01% 357
2023
Q4
$9.57M Buy
591,556
+89,473
+18% +$1.46M 0.01% 391
2023
Q3
$6.18M Buy
+502,083
New +$7.47M 0.01% 402
2021
Q4
Sell
-301,226
Closed -$14.5M 705
2021
Q3
$14.5M Sell
301,226
-162,018
-35% -$7.5M 0.01% 408
2021
Q2
$20.9M Sell
463,244
-14,522
-3% -$643K 0.01% 362
2021
Q1
$23M Sell
477,766
-62,516
-12% -$3.25M 0.02% 339
2020
Q4
$29.1M Buy
540,282
+132,470
+32% +$5.99M 0.02% 295
2020
Q3
$15M Buy
407,812
+12,113
+3% +$450K 0.01% 337
2020
Q2
$12.3M Buy
395,699
+365,352
+1,204% +$10.1M 0.01% 348
2020
Q1
$838K Buy
+30,347
New +$909K ﹤0.01% 510
2019
Q3
Sell
-40,260
Closed -$883K 669
2019
Q2
$883K Buy
40,260
+381
+1% +$8.36K ﹤0.01% 570
2019
Q1
$816K Sell
39,879
-7,699
-16% -$134K ﹤0.01% 570
2018
Q4
$600K Buy
47,578
+4,415
+10% +$65.8K ﹤0.01% 587
2018
Q3
$663K Sell
43,163
-573
-1% -$7.92K ﹤0.01% 600
2018
Q2
$573K Buy
43,736
+6,888
+19% +$75.8K ﹤0.01% 615
2018
Q1
$301K Buy
+36,848
New +$299K ﹤0.01% 634

Other funds holding NEO

Jennison Associates's NEO Position: Q3 2025 in Review

Jennison Associates sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 1,663,905 shares — an estimated $12.2M sold.

Jennison Associates first reported a position in NEO in Q1 2018 and held it in 21 quarters. The position peaked at $29.1M in Q4 2020. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Jennison Associates reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • Jennison Associates sold 1,663,905 NeoGenomics shares in Q3 2025, an estimated $12.2M.
  • Jennison Associates first reported a position in NeoGenomics in Q1 2018 and held it in 21 quarters.
  • Jennison Associates's NeoGenomics position peaked at $29.1M in Q4 2020.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.